
|Articles|August 2, 2015
Ongoing Debate Over High Cost Cholesterol Drugs Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/ongoing-debate-over-high-cost-cholesterol-drugs-hi" target="_blank">View the story "Ongoing Debate Over High Cost Cholesterol Drugs Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
2
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
3
SGLT2 Inhibitors Linked to Lower Atrial Fibrillation Risk, Recurrence
4
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
5












































































































































































































